Summary
Updated Aug 31, 2026
Benjamin J. Zeskind is PRESIDENT AND CEO, Director of Immuneering Corp (IMRX). 3 SEC Form 4 filings on record going back to 2025, most recently on 24 June 2026. Most recent open-market trade: bought $11K of IMRX on 24 June 2026. Lifetime open-market purchases: $46K.
Recent Transactions
3Every recent SEC Form 4 transaction Benjamin J. Zeskind has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Benjamin J. Zeskind files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Peter Feinberg - $226K of IMRX open-market activity in the last 12 months
- Thomas J. Schall - $101K of IMRX open-market activity in the last 12 months
- Brett Matthew Hall - $36K of IMRX open-market activity in the last 12 months
- Harold Eugene Brakewood - $25K of IMRX open-market activity in the last 12 months
- Leah R. Neufeld - $16K of IMRX open-market activity in the last 12 months
- Michael Bookman - $7K of IMRX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Benjamin J. Zeskind?
Benjamin J. Zeskind is a corporate insider, tracked as PRESIDENT AND CEO, Director of Immuneering Corp (IMRX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Benjamin J. Zeskind submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Benjamin J. Zeskind been buying or selling stock?
Recorded transactions: 3 open-market purchases ($46K) and 0 open-market sales across all tracked filings.
Where can I see all of Benjamin J. Zeskind's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Benjamin J. Zeskind and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
